Biochemically Defined HIV-1 Envelope Glycoprotein Variant Immunogens Display Differential Binding and Neutralizing Specificities to the CD4-binding Site
Open Access
- 1 February 2012
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 287 (8) , 5673-5686
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Broad neutralization coverage of HIV by multiple highly potent antibodiesNature, 2011
- Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep SequencingScience, 2011
- Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 BindingScience, 2011
- Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1Science, 2010
- Soluble HIV-1 Env trimers in adjuvant elicit potent and diverse functional B cell responses in primatesJournal of Experimental Medicine, 2010
- Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120Science, 2009
- Improved Induction of Antibodies against Key Neutralizing Epitopes by Human Immunodeficiency Virus Type 1 gp120 DNA Prime-Protein Boost Vaccination Compared to gp120 Protein-Only VaccinationJournal of Virology, 2008
- Broad HIV-1 neutralization mediated by CD4-binding site antibodiesNature Medicine, 2007
- Structural definition of a conserved neutralization epitope on HIV-1 gp120Nature, 2007
- CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5Nature, 1996